MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.330
-0.010
-0.75%
After Hours: 1.340 +0.01 +0.75% 19:59 12/31 EST
OPEN
1.340
PREV CLOSE
1.340
HIGH
1.355
LOW
1.310
VOLUME
218.34K
TURNOVER
--
52 WEEK HIGH
5.40
52 WEEK LOW
1.120
MARKET CAP
45.73M
P/E (TTM)
-3.5581
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TELO last week (1222-1226)?
Weekly Report · 12/29/2025 09:14
Telomir Pharmaceuticals Approves New CEO Compensation Package Including Incentives and Salary Increase
Reuters · 12/22/2025 11:03
Weekly Report: what happened at TELO last week (1215-1219)?
Weekly Report · 12/22/2025 09:14
Telomir Pharmaceuticals reports results from safety studies for Telomir-1
TipRanks · 12/18/2025 12:45
Telomir Pharma Announces Results From Comprehensive Series Of IND-Enabling GLP Toxicology And Safety Pharmacology Studies For Telomir-1
Benzinga · 12/18/2025 12:32
Telomir Pharmaceuticals Reports Favorable Safety Results for Lead Cancer Therapy Telomir-1
Reuters · 12/18/2025 12:30
Telomir Pharmaceuticals Reports Positive IND-Enabling Study Results
TipRanks · 12/17/2025 21:38
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/17/2025 21:05
More
About TELO
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company is focused on the development of Telomir-1, a novel small molecule metal ion chelator and regulator designed to lengthen the DNA’s protective telomere caps, which are crucial in the aging process. Telomir 1 is being developed to protect stem cells by elongating and stimulating the telomeres to sustain self-renewal. Telomir-1 helps protect against age-related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease (a genetic disorder leading to toxic copper buildup in the body), and age-related macular degeneration (AMD), as well as Type 2 Diabetes, cancer, and Alzheimer’s disease. It is exploring the potential of Telomir-1 with ongoing research in animals and then in humans. It is focused on developing and commercializing TELOMIR-1, proposed to be dosed orally, with the aim of promoting longevity and enhancing overall quality of life.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.